Jessica Tuchman Mathews has bought HBI on 2 days since May 2016
Director at Hanesbrands Inc.
SEC CIK 0001380274 · Filings on SEC.gov ↗
Jessica Tuchman Mathews's record
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
5 filings since May 2016, newest first
About Jessica Tuchman Mathews
Jessica Tuchman Mathews is an American international affairs expert and corporate director who serves on the board of Hanesbrands Inc. (HBI) as a Director.( A longtime corporate insider at Hanesbrands, she has reported ownership of more than 140,000 HBI shares and has previously executed insider transactions in the company’s stock, including a notable sale of 15,000 shares in December 2018.( In addition to Hanesbrands, Mathews has served as a director of SomaLogic, a leading biotechnology firm in proteomics, expanding her governance experience across both consumer and life-sciences sectors.(
Beyond her corporate roles, Mathews is a distinguished fellow and former president of the Carnegie Endowment for International Peace, where she led the organization for 18 years.( Her career has included senior positions in the U.S. government, notably as Director of the Office of Global Issues at the National Security Council, as well as leadership and research roles in prominent nonprofits such as the World Resources Institute and the Council on Foreign Relations.( An accomplished writer on foreign policy, science, and global governance, she holds a PhD in molecular biology from the California Institute of Technology and graduated magna cum laude from Radcliffe College, underscoring the scientific and analytical foundation of her work in international affairs and corporate oversight.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.